Open access · OA
via OpenAlex
Association of Adiponectin Mutation With Type 2 Diabetes
Hidehiko Kondo, Iichiro Shimomura, Yuko Matsukawa, Masahiro Kumada, Masahiko Takahashi, Morihiro Matsuda, Noriyuki Ouchi, Shinji Kihara, Toshiharu Kawamoto, Satoru Sumitsuji, Tohru Funahashi, Yūji Matsuzawa
Diabetes · 2002 · ▲ 385 citations
Abstract
Adiponectin, also referred to as AdipoQ or ACRP30, is a plasma protein produced and secreted exclusively from adipose tissue. The protein contains a collagen-like domain and a C1q-like globular domain. A protease-generated globular segment enhances fatty acid oxidation in muscles, thereby modulating lipid and glucose metabolism. Plasma adiponectin levels are inversely correlated with the severity of insulin resistance. A recent genome-wide scan study mapped a susceptibility locus for type 2 diabetes and the metabolic syndrome to chromosome 3q27, where the adiponectin gene is located. Here, we screened Japanese patients with type 2 diabetes and age- and BMI-matched nondiabetic control subjects for mutations in adiponectin gene. We identified four missense mutations (R112C, I164T, R221S, and H241P) in the globular domain. Among these mutations, the frequency of I164T mutation was significantly higher in type 2 diabetic patients than in age- and BMI- matched control subjects (P < 0.01). Furthermore, plasma adiponectin concentrations of subjects carrying I164T mutation were lower than those of subjects without the mutation. All the subjects carrying I164T mutation showed some feature of metabolic syndrome, including hypertension, hyperlipidemia, diabetes, and atherosclerosis. Our findings suggest that I164T mutation is associated with low plasma adiponectin concentration and type 2 diabetes.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2337/diabetes.51.7.2325
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Kondo, H., Shimomura, I., Matsukawa, Y., Kumada, M., Takahashi, M., Matsuda, M., Ouchi, N., Kihara, S., Kawamoto, T., Sumitsuji, S., Funahashi, T., & Matsuzawa, Y. (2002). Association of Adiponectin Mutation With Type 2 Diabetes. <em>Diabetes</em>. https://doi.org/10.2337/diabetes.51.7.2325
Vancouver
Kondo H, Shimomura I, Matsukawa Y, Kumada M, Takahashi M, Matsuda M, et al. Association of Adiponectin Mutation With Type 2 Diabetes. Diabetes. 2002. doi:10.2337/diabetes.51.7.2325.
BibTeX
@article{hidehiko2002Associ,
title = {Association of Adiponectin Mutation With Type 2 Diabetes},
author = {Hidehiko Kondo and Iichiro Shimomura and Yuko Matsukawa and Masahiro Kumada and Masahiko Takahashi and Morihiro Matsuda and Noriyuki Ouchi and Shinji Kihara and Toshiharu Kawamoto and Satoru Sumitsuji and Tohru Funahashi and Yūji Matsuzawa},
journal = {Diabetes},
year = {2002},
doi = {10.2337/diabetes.51.7.2325},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of International Medical Research 2009
Citation only
The Relationship between Adipokines, Metabolic Parameters and Insulin Resistance in Patients with Metabolic Syndrome and Type 2 Diabetes
Metabolism 2013
Citation only
U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: The Fukuoka Diabetes Registry
Diabetes Care 2014
Open access · OA
Leukocyte Profiles Differ Between Type 1 and Type 2 Diabetes and Are Associated With Metabolic Phenotypes: Results From the German Diabetes Study (GDS)
Diabetes Care 2008
Open access · CC-BY
Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3
International Journal of Obesity 2006
Citation only
Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes
Diabetes Care 2007
Citation only